Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06146205

The Hip Fracture Surgical Approach Trial

The HIFSAT study will compare the standard direct lateral approach to hemiarthroplasty to a new muscle sparing approach (SPAIRE) in femoral neck fracture patients.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Diakonhjemmet Hospital

Oslo, 0319, Norway

About this study

Femoral neck fractures are mostly treated with a hemiarthroplasty, where the fractured femoral head is replaced with a metal implant. The most common surgical approach to hemiarthroplasty has been the lateral approach, in which the gluteus medius tendon is partially released from the greater trochanter. Hip pain and limping is not uncommon after this approach has been used. A new surgical approach (SPAIRE) has been developed to alleviate this problem, and in this method the surgeon approaches the injured hip joint from posterior, preserving most of the muscles and tendons around the hip. This trial is designed to assess if this new SPAIRE approach leads to better results than the lateral approach in patients with femoral neck fractures.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Femoral neck fracture
  • Clinical indication for hemiarthroplasty
  • Age over 50 years

Exclusion criteria

  • Previous hip implants in the same hip
  • Patients assessed to be in a terminal state with an expected survival of less than 1 week
  • Other factors that makes follow-up impossible

Treatment and study plan

direct lateral approach

Procedure

The hip joint is approached from laterally, and parts of the gluteus medius tendon is released from the greater trochanter before the hip joint is entered from the anterior side.

Other names: Hardinge approach

SPAIRE

Procedure

The hip joint is entered from posterior, and the approach preserves the external rotators of the hip joint.

Other names: Muscle-sparing modification of the posterior approach

Primary outcomes

  1. Harris Hip Score ( HHS)

    Time frame: 4 months

    Harris Hip Score (HHS) is an outcome measure for hip-related symptoms. The score is based on both patient-reported information and clinical examination, and is administered by a qualified health care professional. It covers four domains: Pain, function, absence of deformity and range of motion. The score ranges from 0 (worst) to 100 (best).

Secondary outcomes

  1. Harris Hip Score (HHS)

    Time frame: 12 and 24 months

    Harris Hip Score (HHS) is an outcome measure for hip-related symptoms. The score is based on both patient-reported information and clinical examination, and is administered by a qualified health care professional. It covers four domains: Pain, function, presence of deformity and range of motion. The score ranges from 0 (worst) to 100 (best).

  2. Oxford Hip score

    Time frame: 4,12 and 24 months

    Oxford Hip Score(OHS) is a patient reported outcome measure( PROM), OHS is designed to assess outcome after total hip replacement. It has 6 questions on pain and 6 questions on mobility. 5 categories of answer from worst to best. The range is 0-48.

  3. EuroQol-5d-5l

    Time frame: 4,12 and 24 months

    EuroQol-5d-5l is a descriptive system comprises 5 dimensions: Mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the 5 dimensions can be combined into a 5-digit number that describes the patient's health state, and these digits can be converted into a single numerical value reflecting how the health state is according to the preferences of the general population of a country/region.

  4. Trendelenburg test

    Time frame: 4,12 and 24 months

    This is a test to identify weakness in gluteal muscles, that can be seen in patients after hip surgery. Unilateral weakness in the gluteal muscles can for instance because nerve damage, trauma to the muscle or rupture of the tendon. The test will be performed as described by Hardcastle and Wade. The patient will be asked to raise their foot from the ground with 30º of hip flexion. The patient will be instructed to raise the non-stance side of the pelvis as high as possible with the examiner supporting the patient by holding their hands if needed. If the patient is not able to maintain this position for 30 seconds, or not being able to raise the hip of the non-stance side to above the level of the stance-side, the Trendelenburg test is considered positive.

  5. New Mobility Score (NMS)

    Time frame: 4,12 and 24 months

    NMS consists of 3 questions about ambulation indoor, outdoor and the ability to go shopping. Each question has 4 alternative answers yielding 0-3 points, and the maximum score is 9.

  6. Short Physical Performance Battery (SPPB)

    Time frame: 4, 12, an 24 months

    The Short Physical Performance Battery is an assessment tool made specific for screening of physical function among older adults. SPPB has 3 different tests: Balance, walking speed and rising from a chair. Scorings range from 0-12, best possible is 12.

  7. Numerical Pain Rate Scale( NPRS)

    Time frame: 4, 12 and 24 months

    Unidimensional measure of pain intensity in adults, describing pain extreme from 0 no pain at all to 10 the worst pain imaginable.

  8. Duration of surgery

    Time frame: 1.st day after surgery

    Duration of the operation in minutes

  9. Preferred Walking Speed

    Time frame: 4,12 and 24 months

    A four-meter distance is marked on the floor, and the patients are instructed to walk this distance in their normal speed, as if they were walking down a street. The distance is walked twice, and the fastest speed is recorded. The subject can use any walking aids, and this is recorded.

  10. Repeated Chair Stand Test

    Time frame: 4,12 and 24 months

    In the repeated chair stand test the participants are asked to fold their arms across their chest (the armrests shall not be not used) and stand up from the chair 5 times. This is timed by the examiner, and points are given from 0 to 4

  11. Cumulated Ambulation Score

    Time frame: 1-5 days after surgery

    This will be recorded at day 1-3 for all patients. This score assesses the patients' early mobility by evaluating their ability to rise from bed, rise from a chair and walk indoor (walking aids permitted).

  12. Timed up and go test

    Time frame: 4,12 and 24 months

    This test measures the time that the person uses to rise from a chair, walk three meters, turn around and walk back to the chair, and sit down again, turning 180 degrees. The person can use any mobility aids that he/she would normally use. The TUG test is being scored by the total time measured

  13. Use of analgesia during admission

    Time frame: 1. day after surgery

    Analgesia during the first calendar day after surgery will be recorded as morphine equivalents according to a calculation table published by the Norwegian Directorate of Health.

  14. Adverse events

    Time frame: 0-24 months

    Any adverse events will be recorded during the whole study period

  15. Days Alive At Home (DAH)

    Time frame: 4,12 and 24 months

    Days alive and at home will be measured at 4,12 and 24 months. Patients wish to stay most of their lives at home, this measurement will tell us how long they could stay home and if they came home after their hip fracture.

Other outcomes

  1. Grip strength

    Time frame: Day 1-5 after surgery, 4,12 and 24 months

    Sarcopenia is associated with low grip strength. The measurements will be taken with the patient sitting, with the elbow in 90° flexion and the shoulder adducted and neutrally rotated. The second handle position will be used for all participants. Two trials on each side will be conducted, starting with the dominant hand.

  2. Patient Acceptable symptom State

    Time frame: 4,12 and 24 months

    Question about the patient´s satisfaction of the current state of their hip, and another question on whether they consider the treatment of their hip fracture to be a success or failure. They will also record a visual analogue scale of their satisfaction with the result of the surgery, ranging from "very satisfied" to "very dissatisfied".

  3. Blood transfusion

    Time frame: 1st day after surgery until discharge, assessed up to 10 days

    Units of blood transfusion given to the patient during admission

  4. Conventional radiographs of the operated hip

    Time frame: 1.st day after surgery and at 4 months after surgery

    Conventional radiographs will be taken postoperatively and at 4 months according to the standardized procedures for post-operative hip examinations of the radiology department. Using specialized computer software (Sectra Workstation IDS7 v.21 with orthopedic templating module Sectra Orthostation v15.1, Sectra AB, Linköping, Sweden), leg length difference, and hip offset compared to the uninjured hip will be recorded. In patients with a contralateral hip fracture this is not possible, but some of these patients will have available pre-fracture examinations that can be utilized for comparison. Femoral stem varus/valgus angulation (frontal view) and retroversion/anteversion (lateral view) will also be recorded

  5. Body Mass Index

    Time frame: 4, 12 and 24 months

    Recorded with objective weight and height measurements.

  6. Place of return from hospital

    Time frame: 4 months

    Place of return from hospital will be recorded, and at later visits the type of dwelling since the last visit will be recorded. We will differentiate between institution dwelling and community dwelling.

  7. Clinical Frailty Scale

    Time frame: 4, 12 and 24 months

    Assessment of frail patients, grades from 1 (very fit patient) to 9 (terminally ill).

Sponsors and collaborators

Lead sponsor

Diakonhjemmet Hospital

Other

Collaborators

  • Oslo University Hospital
  • University Hospital, Akershus

Registry information

Acronym: HIFSAT

Important dates

Study start
2024
Primary completion
2026
Study completion
2028
First posted
Nov 24, 2023
Registry last updated
Mar 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.